Scientists probe mitochondrial link to lung disease
NCT ID NCT07474220
First seen Jun 27, 2026 · Last updated Jul 07, 2026 · Updated 2 times
Summary
This study looks at a protein called SLC25A48 in blood cells of 180 people with or without COPD. Researchers want to see if its levels are linked to inflammation and disease progression. The goal is to better understand COPD, not to test a treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC OBSTRUCTIVE PULMONARY DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Cardinal Tien Hospital
NOT_YET_RECRUITINGNew Taipei City, 23148, Taiwan
-
Fu Jen Catholic University Hospital, Fu Jen Catholic University
RECRUITINGNew Taipei City, 24352, Taiwan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Smart breathing machines at home: a new way to predict COPD crises?
- Breathing easy? new X-Ray method may spot COPD decline early
- Could a common heart drug cut COPD hospitalizations?
- Which inhaler breathes better? a Head-to-Head COPD showdown
- Could tiny lung valves revive heart and muscle strength in COPD?
- One lung or two? surgery trial aims to find the best approach for severe COPD